Wiemels JL - Search Results

1

Molecular biomarkers for the study of childhood leukemia.

Smith MT, McHale CM, Wiemels JL, Zhang L, Wiencke JK, Zheng S, Gunn L, Skibola CF, Ma X, Buffler PA. Smith MT, et al. Among authors: wiemels jl. Toxicol Appl Pharmacol. 2005 Aug 7;206(2):237-45. doi: 10.1016/j.taap.2004.11.026. Toxicol Appl Pharmacol. 2005. PMID: 15967214 Review.

2

Chemical exposure, ras oncogene activation, and acute myeloid leukemia.

Smith MT, Wiemels J, Rothman N, Linet MS. Smith MT, et al. J Natl Cancer Inst. 1992 Nov 4;84(21):1614-5. doi: 10.1093/jnci/84.21.1614. J Natl Cancer Inst. 1992. PMID: 1433339 No abstract available.

3

Genotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

Wiencke JK, Wiemels J. Wiencke JK, et al. Mutat Res. 1995 Jun;339(2):91-119. doi: 10.1016/0165-1110(95)90005-5. Mutat Res. 1995. PMID: 7791804 Review. No abstract available.

4

hprt mutation frequency among workers exposed to 1,3-butadiene in China.

Hayes RB, Xi L, Bechtold WE, Rothman N, Yao M, Henderson R, Zhang L, Smith MT, Zhang D, Wiemels J, Dosemeci M, Yin S, O'Neill JP. Hayes RB, et al. Toxicology. 1996 Oct 28;113(1-3):100-5. doi: 10.1016/0300-483x(96)03433-6. Toxicology. 1996. PMID: 8901888

5

Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene.

Smith MT, Zhang L, Wang Y, Hayes RB, Li G, Wiemels J, Dosemeci M, Titenko-Holland N, Xi L, Kolachana P, Yin S, Rothman N. Smith MT, et al. Cancer Res. 1998 May 15;58(10):2176-81. Cancer Res. 1998. PMID: 9605763

6

Enhancement of myeloid cell growth by benzene metabolites via the production of active oxygen species.

Wiemels J, Smith MT. Wiemels J, et al. Free Radic Res. 1999 Feb;30(2):93-103. doi: 10.1080/10715769900300101. Free Radic Res. 1999. PMID: 10193577

7

Modulation of the toxicity and macromolecular binding of benzene metabolites by NAD(P)H:Quinone oxidoreductase in transfected HL-60 cells.

Wiemels J, Wiencke JK, Varykoni A, Smith MT. Wiemels J, et al. Chem Res Toxicol. 1999 Jun;12(6):467-75. doi: 10.1021/tx9800811. Chem Res Toxicol. 1999. PMID: 10368308

8

Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.

Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT. Larson RA, et al. Blood. 1999 Jul 15;94(2):803-7. Blood. 1999. PMID: 10397748 Free article.

9

Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults.

Smith MT, Wang Y, Kane E, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G. Smith MT, et al. Among authors: wiemels jl. Blood. 2001 Mar 1;97(5):1422-6. doi: 10.1182/blood.v97.5.1422. Blood. 2001. PMID: 11222389 Free article.

10

Molecular characterization of genomic AML1-ETO fusions in childhood leukemia.

Xiao Z, Greaves MF, Buffler P, Smith MT, Segal MR, Dicks BM, Wiencke JK, Wiemels JL. Xiao Z, et al. Among authors: wiemels jl. Leukemia. 2001 Dec;15(12):1906-13. doi: 10.1038/sj.leu.2402318. Leukemia. 2001. PMID: 11753612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters